International Trade and Finance, and More from CRS
New and updated reports from the Congressional Research Service include the following.
International Trade and Finance: Overview and Issues for the 115th Congress, December 21, 2016
China-U.S. Trade Issues, updated December 29, 2016
U.S. International Corporate Taxation: Basic Concepts and Policy Issues, updated December 21, 2016
Political Status of Puerto Rico: Brief Background and Recent Developments for Congress, December 28, 2016
U.S. Foreign Aid to Israel, updated December 22, 2016
Iran’s Foreign and Defense Policies, updated December 21, 2016
The Impeachment of South Korea’s President, CRS Insight, December 22, 2016
Nuclear Cooperation with Other Countries: A Primer, updated December 27, 2016
Trade in Services Agreement (TiSA) Negotiations: Overview and Issues for Congress, updated January 3, 2017
New State Abortion Requirements Post-Whole Woman’s Health, CRS Legal Sidebar, January 3, 2017
EPA Regulations: Too Much, Too Little, or On Track?, updated December 30, 2016
Broadband Internet Access and the Digital Divide: Federal Assistance Programs, updated December 28, 2016
Expedited Procedures Governing Senate Consideration of Legislation Waiving a Restriction Related to the Military Service of the Secretary of Defense, CRS Insight, December 27, 2016
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.